Keep up with the latest happenings in Erba

Transasia Bio-Medicals Ltd. donates 5 BiPAP machines to Assam

Date : 07 Jun, 2021

India’s Leading IVD Company has pledged critical medical equipment worth more than Rs. 3 crores to various state governments, as a part of its COVID-relief efforts.


Multiple Publications, May 31, 2021: Transasia Bio-Medicals Ltd., India’s Leading IVD player for whom India comes first, has been actively supporting various state governments in providing faster diagnosis and treatment to COVID patients.

To help the state of Assam in its’ fight against the second wave of the pandemic, Transasia donated 5 BiPAP machines for deployment in various COVID-dedicated hospitals all over Assam. In spite of the current shortage in the availability of these machines, Transasia procured these machines from its global vendors. Dr. Achyut Ch. Baishya, Principal cum Chief Superintendent, Guwahati Medical College and Hospital and Dr. Sasanka Baruah, Head of Department, Urology, Guwahati Medical College and Hospital received them from Monoj Kr. Shome, Regional Sales Manager, Transasia Bio-Medicals Ltd.


As a part of its COVID-relief efforts, Transasia has donated critical equipment including 200 BiPAP machines for oxygen support, 40 hematology analyzers and 30 coagulation analyzers for monitoring disease severity. These equipment worth more than Rs. 3 crores have been donated to several state governments to aid in the treatment of COVID patients.

Transasia’s COVID-19 IgG antibody test, RT PCR kit, and those for critical parameters such as D Dimer, CRP, Ferritin are being effectively employed by thousands of laboratories and hospitals all over India and in over 100 countries to monitor the progression of infection.

Expressing his gratitude to the Vazirani Foundation and Transasia for extending their support to the Assam government, Dr. Achyut Ch. Baishya, Principal cum Chief Superintendent, Guwahati Medical College and Hospital, said, “It’s a timely donation and essential in the fight against Coronavirus. Transasia’s efforts to deliver non-invasive ventilation will benefit many COVID-19 patients struggling to breathe while trying to fight off this virus.”


Added, Dr. Sasanka Baruah, Head of Department, Urology, Guwahati Medical College and Hospital, “We laud Transasia’s ongoing efforts in Assam in preventing, detecting, and responding to the pandemic.”


Speaking on the donation, Suresh Vazirani, Founder & Chairman, Transasia-Erba Group, said, “The second wave is devastating and is taking a toll on the healthcare system of our country. While we are hopeful that things will turn around for India soon, we realized that just hope is not enough. Transasia remains committed to the health of Indians and through our small effort, we intent to reach out to those severely impacted and in urgent need. This is one of the several initiatives that we, through the Vazirani Foundation, intend to continue to use our resources and technology, to aid the Central and state health ministries.”


About Transasia Bio-Medicals Ltd.: Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. It provides doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems, with 70,000+ equipment installed across India. Transasia boasts of 350+ service engineers, 400+ sales and marketing team, 25 zonal offices and 350+ distributors. It is the first Indian company to manufacture and export blood analyzers. In the last two years, Transasia has introduced several new products and technologies in the field of Hematology and Immunology for the IVD industry. Further, all of Transasia’s in-vitro diagnostic instruments manufactured in Mumbai are now USFDA registered. This means Transasia’s ‘Made in India’ products which are currently exported to over 100 countries will now also be available in USA.